The effect of a modified β-cyclodextrin, SBE4-β-CD, on the aqueous stability and ocular absorption of pilocarpine

References

• Chrai S. S., Patton T. F., Mehta A., Robinson J. R. Lacrimal and instilled fluid dynamics in rabbit eye. J. Pharm. Sci. 1973; 62: 1112–1121
   PubMed Web of Science ®Google Scholar
• Lee V. H.L., Robinson J. R. Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits. J. Pharm. Sci. 1979; 68: 673–684
   PubMed Web of Science ®Google Scholar
• Thombre A. G., Himmelstein K. J. Quantitative evaluation of topically applied pilocarpine in the precorneal area. J. Pharm. Sci. 1984; 73: 219–222
   PubMed Web of Science ®Google Scholar
• Suhonen P., Järvinen T., Peura P., Urtti A. Permeability of pilocarpine acid diesters across albino rabbit cornea in vitro. Int. J. Pharm. 1991; 74: 221–228
   Web of Science ®Google Scholar
• Ünlü N., Sumnu M., Hincal A. A. Formulation studies on pilocarpine nitrate ophthalmic solutions. Acta Pharm. Technol. 1989; 35: 38–43
   Web of Science ®Google Scholar
• Sieg J. W., Robinson J. R. Vehicle effects on ocular drug bioavailability II: Evaluation of pilocarpine. J. Pharm. Sci. 1977; 66: 1222–1228
   PubMed Web of Science ®Google Scholar
• Mitra A. K., Mikkelson T. J. Mechanism of transcorneal permeation of pilocarpine. J. Pharm. Sci. 1988; 77: 771–775
   PubMed Web of Science ®Google Scholar
• Choudhury S., Mitra A. K. Kinetics of aspirin hydrolysis and stabilization in the presence of 2-hydroxy-propyl-β-cyclodextrin. Pharm. Res. 1993; 10: 156–159
   PubMed Web of Science ®Google Scholar
• Backensfeld T., Müller B. W., Wiese M., Seydel J. K. Effect of cyclodextrin derivatives on indomethacin stability in aqueous solution. Pharm. Res 1990; 7: 484–490
   PubMed Web of Science ®Google Scholar
• Loftsson T., Balvinsdóttir J., Sigurdardóttir A. M. The effect of cyclodextrins on the solubility and stability of medroxyprogesterone acetate and megestrol acetate in aqueous solution. Int. J. Pharm. 1993; 98: 225–230
   Google Scholar
• Bekers O., Uijtendaal E. V., Beijnen J. H., Bull A., Underberg W. J. M. Cyclodextrins in the pharmaceutical field. Drug Dev. Ind. Pharm. 1991; 17: 1503–1549
   Web of Science ®Google Scholar
• Duchene D., Vaution C., Glomot F. Cyclodextrins, their value in pharmaceutical technology. Drug Dev. Ind. Pharm. 1986; 12: 2193–2215
   Web of Science ®Google Scholar
• Hedges A. R. Minutes of the Sixth International Symposium on Cyclodextrins. Editions de Sante, ParisFrance 1992
   Google Scholar
• Uekama K., Otagiri M. Cyclodextrins in drug carrier systems. CRC Crit. Rev. Ther. Drug Carrier Syst. 1987; 3: 1–40
   PubMed Web of Science ®Google Scholar
• Loftsson T., Fridriksdóttir H., Thorisdóttir S., Stefansson E. The effect of hydroxypropyl methyl-cellulose on the release of dexamethasone from aqueous 2-hydroxypropyl-β-cyclodextrin formulations. Int. J. Pharm. 1994; 104: 181–184
   Web of Science ®Google Scholar
• Usayapant A., Karara A. H., Narurkar M. M. Effect of 2-hydroxypropyl-β-cyclodextrin on the ocular absorption of dexamethasone and dexamethasone acetate. Pharm. Res. 1991; 8: 1495–1499
   PubMed Web of Science ®Google Scholar
• Freedman K. A., Klein J. W., Crosson C. E. Beta-cyclodextrins enhance bioavailability of pilocarpine. Curr. Eye Res. 1993; 12: 641–647
   PubMed Web of Science ®Google Scholar
• Wheeler L. A. The use of inclusion complexes of prostaglandins with Cyclodextrins in the treatment of ocular hypertension. Eur. Pat. O 435 682 A3, 1991
   Google Scholar
• Loftsson T., Fridriksdóttir H., Thorisdóttir S., Stefansson E., Sigurdardóttir A. M., Gudmundsson Ö, Sigthorsson T. 2-Hydroxy-propyl-(3-cyclodextrin in topical carbonic anhydrase inhibitor formulations. Eur. J. Pharm. Sci. 1994; 1: 175–180
   Web of Science ®Google Scholar
• Rajewski R. A., Stella V. J., Tarn M., Waugh W., Thompson D. O. Pharmaceutically useful anionic cyclodextrin derivatives. Pharm. Res. 1992; 9(Suppl.)227
   Google Scholar
• Rajewski R. A. Development and evaluation of the usefulness and parenteral safety of modified Cyclodextrins. Ph.D. Dissertation, University of Kansas, LawrenceKS, USA 1990
   Google Scholar
• Tail R. J., Skanchy D. J., Thompson D. P., Chetwyn N. C., Dunshee D. A., Rajewski R. A., Stella V. J., Stobaugh J. F. Characterization of sulphoalkyl ether derivatives of β-cyclodextrin by capillary electrophoresis with indirect UV detection. J. Pharm. Biomed. Anal. 1992; 10: 615–622
   PubMed Web of Science ®Google Scholar
• Stella V. J., Rajewski R. A. Derivatives of Cyclodextrins exhibiting enhanced aqueous solubility and the use thereof. US Patent 1992; 5: 134, 127
   Google Scholar
• Järvinen T., Järvinen K., Thompson D. O., Stella V. J. Sulfobutyl ether β-cyclodextrin (SBE-β-CD) in eyedrops improves tolerability of a topically applied pilocarpine prodrug in rabbits. J. Ocular Pharmacol. 1994, in press
   Google Scholar
• Wong O., Anderson C., Allaben L., Pabmanabhan R., Lattin G. Stability-indicating assay method for pilocarpine nitrate in reservoirs used in the cystic fibrosis indicator system. Int. J. Pharm. 1991; 76: 171–175
   Web of Science ®Google Scholar
• Gibaldi M., Perrier D. Pharmacokinetics. 2nd edition. Marcel Dekker Inc., New York 1982
   Google Scholar
• Chang S.-C., Bundgaard H., Buur A., Lee V. H. L. Improved corneal penetration of timolol by prodrugs as a means to reduce systemic drug load. Invest. Ophthalmol. Vis. Sci. 1987; 28: 487–491
   PubMed Web of Science ®Google Scholar
• Chien D.-S., Sasaki H., Bundgaard H., Buur A., Lee V. H. L. Role of enzymatic lability in the corneal and conjunctival penetration of timolol ester prodrugs in the pigmented rabbit. Pharm. Res. 1991; 8: 728–733
   PubMed Web of Science ®Google Scholar
• Schoenwald R. D., Huang H.-S. Corneal penetration behavior of β-blocking agents I: Physicochemical factors. J. Pharm. Sci. 1983; 72: 1266–1272
   PubMed Web of Science ®Google Scholar
• Ethier C. R., Ajersch P., Pirog R. An improved ocular perfusion system. Curr. Eye Res. 1993; 12: 765–770
   PubMed Web of Science ®Google Scholar
• Jansen T., Xhonneux B., Mesens J., Borgers M. Beta-cyclodextrins as vehicles in eye-drop formulations: An evaluation of their effects on rabbit corneal epithelium. Lens Eye Toxicity Res. 1990; 7: 459–468
   PubMedGoogle Scholar
• Ellingson C. M., Shoenwald R. D., Barfknecht C. F., Rao C. S., Laban S. L. Rapid toxicological model for use in assessing ocular drugs. Biopharm. Drug Disposit. 1992; 13: 417–436
   PubMed Web of Science ®Google Scholar
• Mosher G. L., Bundgaard H., Falch E., Larsen C., Mikkelson T. J. Ocular bioavailability of pilocarpic acid mono-and diester prodrugs as assessed by miotic activity in the rabbit. Int. J. Pharm. 1987; 39: 113–120
   Google Scholar
• Saettone M. F., Torracca M. T., Pagano A., Giannaccini B., Rodriguez L., Cini M. Controlled release of pilocarpine from coated polymeric ophthalmic inserts prepared by extrusion. Int. J. Pharm. 1986; 86: 159–166
   Google Scholar
• Schoenwald R. D., Ward R. L., DeSantis L. M., Roehrs R. E. Influence of high-viscosity vehicles on miotic effect of pilocarpine. J. Pharm. Sci. 1978; 67: 1280–1283
   PubMed Web of Science ®Google Scholar
• Pop E., Loftsson T., Bodor N. Solubilization and stabilization of a benzylpenicillin chemical delivery system by 2-hydroxypropyl-β-cyclodextrin. Pharm. Res. 1991; 8: 1044–1049
   PubMed Web of Science ®Google Scholar
• Frijlink H. W., Eissens A. C., Schoonen A. J. M., Lerk C. F. The effects of Cyclodextrins on drug absorption II. In vivo observation. Int. J. Pharm. 1990; 64: 195–205
   Web of Science ®Google Scholar
• Nakanishi K., Masada M., Nadai T., Miyajima K. Effect of the interaction of drug-β-cyclodextrin complex with bile salts on the drug absorption from rat small intestinal lumen. Chem. Pharm. Bull. 1989; 37: 211–214
   PubMed Web of Science ®Google Scholar